[A trial of progressive supranuclear palsy with carbamazepine].
We present a 61-year old patient with diagnosis of progressive supranuclear palsy. 2 years after the beginning of her complaints the diagnosis was based on the results of neurological examination. The ENG examination (among others vertical gaze paralysis) and the MR examination (2 of 3 criteria were met). The course of the disease was complicated by epilepsy and the treatment with carbamazepine was commenced. A significant improvement of her neurological and mental status was observed. The authors suggest checking this observation on larger number of patients with PSP.
Klimek
A
A
Oddziału Neurologii W.S.Z. im. M.Kopernika.
Wojciechowska
J
J
Niewinowska-Rupf
K
K
Kobielski
A
A
D000927:Anticonvulsants / Q000627:therapeutic use*; D002220:Carbamazepine / Q000627:therapeutic use*; D004569:Electroencephalography; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D013494:Supranuclear Palsy, Progressive / Q000175:diagnosis / Q000188:drug therapy*; D015899:Tomography, Emission-Computed, Single-Photon
D000927:Anticonvulsants; D002220:Carbamazepine
Próba zastosowania karbamazepiny w postepujacym porazeniu nadjadrowym.